Literature DB >> 8727913

Natural environmental sources of Cryptococcus neoformans var. gattii.

T C Sorrell1, A G Brownlee, P Ruma, R Malik, T J Pfeiffer, D H Ellis.   

Abstract

We sought evidence for new environmental sources of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA (RAPD) analysis of isolates from 29 animals with a restricted territorial range in five Australian states. Twenty-three of the 29 isolates and 45 of 45 eucalypt isolates tested previously exhibited one RAPD profile, VGI. RAPD profile VGII was identified in 6 of 17 isolates from domesticated species but in none of 12 native species. Four VGII isolates originated from an area of Western Australia with no natural stands of known eucalypt host, indicating the existence of at least one unrecognized natural source of C. neoformans var. gattii.

Entities:  

Mesh:

Year:  1996        PMID: 8727913      PMCID: PMC228992          DOI: 10.1128/jcm.34.5.1261-1263.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Cryptococcosis in seven horses.

Authors:  C B Riley; J R Bolton; J N Mills; J B Thomas
Journal:  Aust Vet J       Date:  1992-06       Impact factor: 1.281

2.  Concordance of clinical and environmental isolates of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting.

Authors:  T C Sorrell; S C Chen; P Ruma; W Meyer; T J Pfeiffer; D H Ellis; A G Brownlee
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

3.  Cryptococcosis in cats: clinical and mycological assessment of 29 cases and evaluation of treatment using orally administered fluconazole.

Authors:  R Malik; D I Wigney; D B Muir; D J Gregory; D N Love
Journal:  J Med Vet Mycol       Date:  1992

4.  Cryptococcal meningitis in Papua New Guinea: ecology and the role of eucalypts.

Authors:  I Laurenson; S Naraqi; N Howcroft; I Burrows; S Saulei
Journal:  Med J Aust       Date:  1993-02-01       Impact factor: 7.738

5.  Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C).

Authors:  K J Kwon-Chung; I Polacheck; J E Bennett
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

6.  Epidemiologic differences between the two varieties of Cryptococcus neoformans.

Authors:  K J Kwon-Chung; J E Bennett
Journal:  Am J Epidemiol       Date:  1984-07       Impact factor: 4.897

Review 7.  Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome.

Authors:  D H Mitchell; T C Sorrell; A M Allworth; C H Heath; A R McGregor; K Papanaoum; M J Richards; T Gottlieb
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

8.  Cryptococcus neoformans var. gattii in Australia.

Authors:  D H Ellis
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

9.  Environmental isolation of Cryptococcus neoformans var. gattii from Eucalyptus tereticornis.

Authors:  T J Pfeiffer; D H Ellis
Journal:  J Med Vet Mycol       Date:  1992

10.  Cryptococcus neoformans in tropical northern Australia: predominantly variant gattii with good outcomes.

Authors:  D Fisher; J Burrow; D Lo; B Currie
Journal:  Aust N Z J Med       Date:  1993-12
View more
  26 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

Review 2.  Cryptococcus gattii: a resurgent fungal pathogen.

Authors:  Vishnu Chaturvedi; Sudha Chaturvedi
Journal:  Trends Microbiol       Date:  2011-08-29       Impact factor: 17.079

3.  Clinical and environmental isolates of Cryptococcus gattii from Australia that retain sexual fecundity.

Authors:  Leona T Campbell; James A Fraser; Connie B Nichols; Fred S Dietrich; Dee Carter; Joseph Heitman
Journal:  Eukaryot Cell       Date:  2005-08

4.  Clonality and recombination in genetically differentiated subgroups of Cryptococcus gattii.

Authors:  Leona T Campbell; Bart J Currie; Mark Krockenberger; Richard Malik; Wieland Meyer; Joseph Heitman; Dee Carter
Journal:  Eukaryot Cell       Date:  2005-08

Review 5.  Microreview: capsule-associated genes of Cryptococcus neoformans.

Authors:  Ken Okabayashi; Atsuhiko Hasegawa; Toshi Watanabe
Journal:  Mycopathologia       Date:  2007-01       Impact factor: 2.574

Review 6.  Intestinal Lesion in a Dog Due to Cryptococcus gattii Type VGII and Review of Published Cases of Canine Gastrointestinal Cryptococcosis.

Authors:  Daniel Paiva Barros de Abreu; Carlos Henrique Machado; Mário Tatsuo Makita; Camila Flávia Magalhães Botelho; Fernanda Gomes Oliveira; Cristiano Chaves Pessoa da Veiga; Marilena Dos Anjos Martins; Francisco de Assis Baroni
Journal:  Mycopathologia       Date:  2016-12-17       Impact factor: 2.574

Review 7.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

8.  A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada).

Authors:  S E Kidd; F Hagen; R L Tscharke; M Huynh; K H Bartlett; M Fyfe; L Macdougall; T Boekhout; K J Kwon-Chung; W Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-30       Impact factor: 11.205

9.  The first isolation of Cryptococcus neoformans from Eucalyptus trees in South Aegean and Mediterranean Regions of Anatolia in Turkey despite Taurus Mountains alkalinity.

Authors:  Cağri Ergin; Macit Ilkit; Süleyha Hilmioğlu; Ilknur Kaleli; A Gani Gülbaba; Mustafa Demirci; Selçuk Kaya
Journal:  Mycopathologia       Date:  2004-07       Impact factor: 2.574

10.  Evidence of recombination in mixed-mating-type and alpha-only populations of Cryptococcus gattii sourced from single eucalyptus tree hollows.

Authors:  Nathan Saul; Mark Krockenberger; Dee Carter
Journal:  Eukaryot Cell       Date:  2008-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.